Effects of paclitaxel and docetaxel on egfr-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro

Journal of Chemotherapy

Volumn 16, Issue 4, 2004, Pages 372-380

  Skvortsova, I ^a   Skvortsov, S ^b   Haidenberger, A ^a   Devries, A ^a   Nevinny Stickel, M ^a   Saurer, M ^a   Lukas, P ^a   Seppi, T ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cancer; Docetaxel; Epidermal growth factor receptor (EGFR); Hypoxia; Paclitaxel

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; PACLITAXEL; TAXANE DERIVATIVE;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; OXYGENATION; TUMOR CELL DESTRUCTION;

EID: 3943072342     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.4.372     Document Type: Article

References (34)

1. Choy H. Taxanes in combined modality therapy for solid tumors. Oncology 1999; 13: 23-38.
2. Eisenhauer EA, Vermorken JB. The taxoids: Comparative clinical pharmacology and therapeutical potential. Drugs 1998; 55: 5-30.
3. Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 1997; 48: 353.
4. Schrijvers D, Vermorken JB. Role of taxoids in head and neck cancer. Oncologist 2000; 5: 199-208.
5. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56: 816-825.
6. Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, Andre S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995; 22: 3-16.
7. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of oxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995; 55: 3564-3568.
8. Milas L, Hunter N, Mason KA, Milross C, Peters LJ. Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol 1995; 43 (3): 409-412.
9. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
10. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001; 7: 987-989.
11. Yuan J, Glazer PM. Mutagenesis induced by the tumor microenvironment. Mutat Res 1998; 400: 439-446.
12. Baselga J, Norton L, Masui H. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993; 85: 1327-1333.
13. Fan Z., Baselga J, Masui H. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res 1993; 53: 4637-4642.
14. Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 1989; 9: 1537-1547.
15. Libermann TA, Nusbaum HR, Razon N, Kris R, Schlessinger J. Amplification, enhanced expression, and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 1985; 313: 144-147.
16. Nishi H, Nishi KH, Johnson AC. Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 2002; 62: 827-834.
17. Yoshida K, Tosaka A, Takeuchi S, Kobayashi N. Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994; 73: 1913-1918.
18. Montgomery BR, Guzman J, O'Rourke DM, Stahl WL. Expression of oncogenic epidermal growth factor receptor family kinases induces paclitaxel resistance and alters b-tubulin isotype expression. J Biol Chem 2000, 275 (23): 17358-17363.
19. Moscatello DK, Holgado-Madruga M, Godwiwin AK, et al. Frequent expression of a mutant growth factor receptor in multiple human tumors. Cancer Res 1995; 55: 5536.
20. Laderoute KR, Grant TD, Murphy BJ, Sutherland RM. Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int J Cancer 1992; 52 (3): 428-432.
21. Aapro M. The scientific rationale for developing taxoids. Anticancer Drugs 1996; 7 Suppl 2: 33-36.
22. Garcia P, Braguer D, Carles G, et al. Comparative effects of taxol and Taxotere on two different human carcinoma cell lines. Cancer Chemother Pharmacol 1994; 34 (4): 335-343.
23. Untch M, Untch A, Sevin BU, et al. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay. Anticancer Drugs 1994; 5 (1): 24-30.
24. Zoli W, Flamigni A, Frassineti GL, et al. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers. Breast Cancer Res Treat 1995; 34 (1): 63-69.
25. Osawa H, Aiba K, Uno S. et al. Multi-drug resistant breast cancer responding to chemotherapy with docetaxel (taxotere: TXT) Gan To Kagaku Ryoho 1999; 26 (9): 1329-1333.
26. Giaccia AJ, Koumenis C, Denko N. The influence of tumor hypoxia on malignant progression. In: Vaupel P, Kelleher DK, eds. Tumor Hypoxia. Stuttgart: WVG. 1999: 115-124.
27. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58-65.
28. Lin CR, Chen WS, Kruiger W. Expression cloning of human EGF receptor complementary DNA: Gene amplification and three related messenger RNA products in A431 cells. Science 1984; 224: 843-848.
29. Merlino GT, Xu Y-H, Ishii S, et al. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 1984; 224: 417-419.
30. Ullrich A, Coussens L, Hayflick JS. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418-425.
31. Yoo GH, Piechocki MP, Ensley JF, et al. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res 2002; 8: 3910-3921.
32. Perez-Soler R, Mendelsohn J. Growth factor receptors as a target for therapy. In: Roth JA, Cox JD, Hong WK, eds. Lung cancer. Cambridge: Blackwell. 1998: 309.
33. Chen JG, Horwitz SB. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 2002; 62: 1935-1938.
34. Schimke RT, Kung A, Sherwood SS, Sheridan J, Sharma R. Life, death and genomic change in pertubed cell cycles. Phylos Trans R Soc Lond B Biol Sci 1994; 345: 311-317.